The Joint Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for The Joint in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" The Joint stock.
View analyst ratings for The Joint or view top-rated stocks.

Wall Street analysts have given The Joint a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The Joint wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

The Joint saw a decline in short interest in the month of August. As of August 13th, there was short interest totaling 819,600 shares, a decline of 19.6% from the July 29th total of 1,020,000 shares. Based on an average trading volume of 346,500 shares, the short-interest ratio is currently 2.4 days. Approximately 5.9% of the shares of the stock are short sold.
View The Joint's Short Interest.

The Joint is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for The Joint.

The Joint Corp. (NASDAQ:JYNT) released its earnings results on Thursday, August, 5th. The company reported $0.18 EPS for the quarter, beating the Zacks' consensus estimate of $0.05 by $0.13. The company earned $20.22 million during the quarter, compared to analyst estimates of $17.58 million. The Joint had a net margin of 24.55% and a trailing twelve-month return on equity of 41.46%.
View The Joint's earnings history.

The Joint's stock was trading at $13.61 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, JYNT shares have increased by 611.4% and is now trading at $96.82.
View which stocks have been most impacted by COVID-19.

The Joint issued an update on its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $77 million-$79 million, compared to the consensus revenue estimate of $75.85 million.

6 equities research analysts have issued 12-month target prices for The Joint's stock. Their forecasts range from $54.00 to $150.00. On average, they anticipate The Joint's share price to reach $107.00 in the next year. This suggests a possible upside of 10.5% from the stock's current price.
View analysts' price targets for The Joint or view top-rated stocks among Wall Street analysts.

87 employees have rated The Joint CEO Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among The Joint's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to The Joint include InterDigital (IDCC), Franchise Group (FRG), Liberty Tax (TAXA), Acacia Research (ACTG), VirnetX (VHC), Quarterhill (QTRHF), Pendrell (PCOA), Research Frontiers (REFR), Network-1 Technologies (NTIP), Health Discovery (HDVY), Xcel Brands (XELB), Mills Music Trust (MMTRS), Micro Imaging Technology (MMTC), ARC Group (RLLY) and ARC Group (ARCK).
View all of JYNT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other The Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Raytheon Technologies (RTX), salesforce.com (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).

(JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

The Joint trades on the NASDAQ under the ticker symbol "JYNT."

The Joint's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.16%), FMR LLC (7.23%), Vanguard Group Inc. (6.32%), Next Century Growth Investors LLC (3.29%), State Street Corp (3.00%) and Skylands Capital LLC (2.87%). Company insiders that own The Joint stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel and Ronald V Davella.
View institutional ownership trends for The Joint.

JYNT stock was sold by a variety of institutional investors in the last quarter, including SW Investment Management LLC, General Equity Holdings LP, Next Century Growth Investors LLC, Wasatch Advisors Inc., Grandeur Peak Global Advisors LLC, First Light Asset Management LLC, AWM Investment Company Inc., and Scholtz & Company LLC. Company insiders that have sold The Joint company stock in the last year include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, and Ronald V Davella.
View insider buying and selling activity for The Joint or view top insider-selling stocks.

JYNT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Invesco Ltd., Vanguard Group Inc., State Street Corp, Dimensional Fund Advisors LP, Principal Financial Group Inc., Millennium Management LLC, and Wolverine Trading LLC. Company insiders that have bought The Joint stock in the last two years include Bandera Partners Llc, and Jake Singleton.
View insider buying and selling activity for The Joint or or view top insider-buying stocks.

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of JYNT stock can currently be purchased for approximately $96.82.

The Joint has a market capitalization of $1.39 billion and generates $58.68 million in revenue each year. The company earns $13.17 million in net income (profit) each year or $0.30 on an earnings per share basis.

The Joint employs 325 workers across the globe.

The official website for The Joint is www.thejoint.com.

The Joint is headquartered at 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260.

The Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at (480) 245-5960 or via email at [email protected].